Will scars be visible after limb lengthening? A method-by-method honest answer.

PRECICE 2 is an internal magnetic nail. The bone is cut, the nail is inserted, and the device is lengthened by an external remote that magnetically rotates the internal mechanism. There is no external hardware bolted through the skin.

A femur lengthening with PRECICE 2 leaves two incisions per leg. The first sits at the hip — the surgeon enters near the greater trochanter to thread the nail down the canal. The second sits at the knee, where the surgeon makes the bone cut through a small approach above the joint. Each incision is 1 to 3 cm. Surgeons place them inside skin creases where possible.

A tibia lengthening with PRECICE 2 also leaves two incisions per leg. One at the knee (proximal entry, near the patellar tendon) and one at the ankle (distal locking screws). Again 1 to 3 cm each.

For the first 6 to 12 months these scars are pinkish. By 18 to 24 months they fade to silver lines, often barely visible at conversational distance. Most PRECICE patients describe the year-two scar visibility as 'invisible unless you know where to look.'

LON (Lengthening Over Nail) combines an internal nail with an external fixator. You get both sets of scars.

The internal nail leaves the same 1 to 3 cm incisions as PRECICE 2 — two per leg. On top of that, the external fixator adds 6 to 10 pin sites per leg, distributed along the femur or tibia. Each pin enters through a small puncture, typically 3 to 5 mm wide.

During active lengthening, the fixator is on the leg and the pin sites are open. Pin-site infection rates run 20 to 40 percent across LON case series, which is why daily pin-site care is non-negotiable. Once distraction ends and consolidation is complete, the fixator is removed. The pin sites then heal as small round scars.

Pin-site scars fade but they do not disappear. They appear as a faint dot pattern along the lengthened bone, visible up close for life. Most LON patients describe them as obvious in a swimsuit at 6 months, faded to subtle at 2 years, and still locatable by touch indefinitely.

Dr. Yunus Öç and Dr. Yuksel Yurttas in Istanbul, both LON-heavy practices, publish patient photos at 12 and 24 months that show this pattern clearly. Ask any LON-focused surgeon for unretouched two-year photos before deciding.

Ilizarov is the highest scar burden. The external frame uses 8 to 16 pin sites per leg, depending on the construct. Each pin enters through the skin and exits the other side — so a single transfixion pin can leave four puncture marks if you count both legs and both sides.

The frame stays on the leg for the entire distraction plus consolidation phase, which can be 6 to 12 months. Pin-site dressings are changed daily. Infection rates at the pin sites run 30 to 50 percent across published Ilizarov series.

Once the frame comes off, the pin sites heal as small round scars. The pattern is the most visible of any LL method. A trained observer can identify an Ilizarov-treated leg from across a swimming pool by the dot distribution along the tibia. The scars fade over years but the pattern remains identifiable.

Dr. Mortaz in Yazd, Iran, and the Russian Ilizarov Center in Kurgan are two of the world's highest-volume Ilizarov practices. Both publish long-term patient photos. The visible pin-site pattern is consistent across patients and surgeons — it is a feature of the method, not a sign of poor technique.

Where the scar sits matters as much as the scar itself. Thigh scars are easy to hide. The skin on the thigh is thick, less reactive to wound healing, and almost always under clothes in daily life. Shin and calf scars are harder to hide — shorts, swimwear, and even tighter pants reveal them.

PRECICE 2 femur incisions sit at the hip crease and just above the knee. Both are inside crease lines or easily hidden by shorts.

PRECICE 2 tibia incisions sit at the knee and ankle. The ankle scar is the most visible LL scar across all methods — it sits on thin skin with little subcutaneous fat, and shoes, sandals, and most footwear do not cover it.

LON and Ilizarov pin sites distribute along the bone they are stabilizing. A LON femur leaves dots along the thigh — hideable. A LON tibia leaves dots along the shin — exposed.

If your method choice is flexible, this is a real input: a femur LL with PRECICE 2 produces the most easily hidden scars of any cosmetic LL option.

Linear surgical scars (PRECICE incisions) follow a predictable timeline. The first 3 months they are red, raised, and itchy. Months 3 to 6 they flatten. Months 6 to 12 they shift from red to pink. By 18 to 24 months they are silver — visible only as a line, not a discoloration.

Pin-site scars (LON and Ilizarov) follow a different path. They look pink and slightly puckered at 3 months. By 6 to 12 months they are dot-shaped white marks. They continue to fade for years but do not disappear. At 5 years, a pin-site pattern is still locatable by trained eye.

Skin tone matters. Darker skin tones are more prone to keloid or hypertrophic scarring at the incision and pin sites. Surgeons in higher-melanin patient populations often use silicone sheeting prophylactically from the first dressing change. Asian and Middle Eastern patients should ask about scar-management protocol up front.

Keloid risk is genetic. If you have keloid history elsewhere on your body, raise it before you book. The surgeon may recommend triamcinolone injections at the suture line as a preventive.

Three interventions have meaningful evidence behind them. Silicone strips or sheets, applied 12 to 23 hours per day during the first year, reduce hypertrophic scarring. Plastic surgery societies treat silicone as first-line. Start at 4 weeks post-op, once the incision is closed and dry.

Laser resurfacing at 12+ months can improve appearance of mature scars. Fractional CO2 and pulsed dye lasers are the workhorse modalities. Cost runs $800 to $3,000 across 2 to 4 sessions. The improvement is real but not dramatic — laser fades the scar by 20 to 40 percent on average, not 100 percent.

Surgical revision is a last resort for hypertrophic or contracted scars. A plastic surgeon excises and re-closes. Outcome depends on technique and on the patient's underlying healing pattern.

Vitamin E oil, despite folk popularity, has minimal evidence. Onion-extract topicals are marginal. Coconut oil is moisturizing but not scar-modifying.

Most important: protect new scars from sun. UV exposure on a healing scar permanently darkens it. SPF 50 over any LL scar for the first year, even in winter, is the single best free intervention.

The PMC11415641 case report (O'Halloran et al., JPRAS Open) includes a post-removal photograph of a patient's lower limb after an internal-nail cosmetic lengthening. The image shows linear surgical scars from the nail insertion at the knee and ankle, plus residual pin-site marks from a prior external fixator on the same limb.

What to notice in clinical photos like this: the linear scars are visible but inactive — pale, narrow, no surrounding redness. The pin-site marks are small round depressions, fully healed, but still identifiable. The patient is fully recovered. This is what 'invisible scars' actually looks like in published documentation, as opposed to the airbrushed before/after images on clinic marketing pages.

This is also the photo to ask your surgeon for. Not a glossy 2-year retouch. The clinical record. A surgeon comfortable with their results will share it.

Patient priorities differ by culture. Across our directory's patient interviews, three distinct attitudes show up.

In East Asian markets (South Korea, Japan, Vietnam), bikini-line scars and ankle-cuff scars are the dominant aesthetic concern. Patients prefer methods that leave fewer, smaller, hideable scars. PRECICE 2 dominates these markets.

In Middle Eastern and Russian markets, scar visibility is less weighted against cost. Patients accept Ilizarov pin-site patterns in exchange for the price advantage and the high-volume surgeon experience.

In European and US cosmetic markets, scar visibility is highly weighted. Internal-nail methods are the near-default. Patients who choose LON or Ilizarov for cost reasons consistently raise scar regret in long-term forums.

None of this is universal. The point is that scar tolerance is personal and culturally informed. Decide before the surgery, not after.

Four specific questions get past the marketing layer.

First: show me three of your patient photos at 12, 24, and 36 months post-op, with my skin tone and my method. Generic stock photos do not count.

Second: what is your hypertrophic scar rate? Surgeons who track this number publish it; surgeons who do not, do not. Both signals matter.

Third: what is your standard scar-management protocol? Silicone sheeting, taping, sun protection — these should already be a written protocol, not improvised at discharge.

Fourth: if I develop a keloid or hypertrophic scar at one of these sites, what is the revision plan? A surgeon with a clear answer has thought about it. A surgeon who has not has not.

The answers will not tell you the scars will be invisible. They will tell you whether the surgeon is honest about what scars look like and prepared for what to do if they heal badly. That is the right bar.